Investigating new treatments for HIV, TB, and hepatitis B.
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
This study is looking at different chemicals to find new treatments for HIV, tuberculosis, and hepatitis B, so that patients can have better options to fight these infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gryphon Scientific, LLC NIH-funded |
| Lab location | 1 site (Takoma Park, United States) |
| Project ID | NIH-11167409 on NIH RePORTER |
What this research studies
This research focuses on analyzing chemical structures and their therapeutic activities to identify potential treatments for HIV, tuberculosis (TB), and hepatitis B virus (HBV). By surveying chemical and biological information, the project aims to develop analytical tools that will aid in the rational selection of effective therapies. Patients may benefit from new treatment options that could emerge from this research, which seeks to enhance the understanding of how different compounds can combat these serious infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with HIV, TB, or hepatitis B virus.
Not a fit: Patients with conditions unrelated to HIV, TB, or HBV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective therapies for patients suffering from HIV, TB, and HBV.
How similar studies have performed: Previous research has shown success in identifying therapeutic compounds for similar viral infections, indicating that this approach has potential.
Where this research is happening
Takoma Park, United States
- Gryphon Scientific, LLC — Takoma Park, United States (Active)
Researchers
- Principal investigator: Sumner, Louise — Gryphon Scientific, LLC
- Study coordinator: Sumner, Louise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.